Malignant rhabdoid tumor (MRT), a highly aggressive cancer of young children, displays inactivation or loss of the hSNF5/INI1/SMARCB1 gene, a core subunit of the SWI/SNF chromatin remodeling complex, in primary tumors and cell lines. We have previously reported that reexpression of hSNF5 in some MRT cell lines causes a G1 arrest via p21 CIP1/WAF1 (p21) mRNA induction in a p53 independent manner. However, the mechanism(s) by which HSNF5 reexpression activates gene transcription remains unclear. We initially searched for other HSNF5 target genes by asking whether HSNF5 loss altered regulation of other consensus p53 target genes.
Introduction
Malignant rhabdoid tumor is a rare and extremely aggressive childhood cancer, originally described as an unfavorable histological variant of the pediatric renal Wilms' tumor (1) . The most common locations are in the kidney and central nervous system, although MRTs may arise in almost any site (2, 3) . Despite significant advances in treatment, for MRTs diagnosed before the age of 6 months, patient survival at 4 years drops to ∼8.8% (4) . Therefore, improved patient outcome requires a better understanding of malignant rhabdoid tumorigenesis and the development of novel therapeutic strategies. The common genetic alteration in MRTs is inactivation of hSNF5 (also known as SMARCB1, INI1, and BAF47), located in chromosome band 22q11.2 (5) , that implicates the loss of hSNF5 function as the primary cause of these tumors (6) . Therefore, the elucidation of hSNF5 function should lead to the identification of the key molecular steps necessary for MRT tumorigenesis.
hSNF5 is a component of the SWI/SNF chromatin-remodeling complex. SWI/SNF complexes are ATP-dependent chromatin remodeling complexes that regulate gene transcription by causing conformational changes in chromatin structure (7) . SWI/SNF subunits can be sub classified into three categories: (1) ATPase subunit (either BRG1 or BRM), (2) core subunits (hSNF5, BAF155 and BAF170), (3) accessory subunits (BAF53, BAF57, BAF180 and others) (8) . How loss of the core SNF5 subunit leads to the development of a rare pediatric cancer remains one of the most challenging questions in the cancer epigenetic field.
Our previous study demonstrated that while hSNF5 reexpression in MRT cells increases both p21 CIP1/WAF1 and p16 INK4A expression during the induction of G1 cell cycle arrest, p21 CIP1/WAF1 upregulation precedes p16 INK4A . Furthermore, we demonstrated that p21 CIP1/WAF1 transcription shows both p53 dependent and independent mechanisms of induction after hSNF5 reexpression. hSNF5 was confirmed to bind to the p21 CIP1/WAF1 promoter by ChIP (chromatin immunoprecipitation) analysis (9) . However, little is known about how hSNF5 activates transcription at its target promoters.
Therefore, in this study, we initially sought additional HSNF5 regulated genes to characterize the effects of HSNF5 reexpression of its target genes. We focused on HSNF5 regulation of other p53 target genes because mutations that inactivate the p53 pathway rarely appear in MRTs (10, 11) . We assessed whether hSNF5 regulates the transcription of representative p53 target genes by Q-RT-PCR and Western blotting. We then clarified how hSNF5 regulates its target genes by performing ChIP assays for hSNF5, histone modifications and SWI/SNF complexes. Our results show that hSNF5 can regulate its target genes either through its modulation of SWI/SNF complex activity or recruitment of complementary transcriptional factors. We also establish the NOXA/PMAIP1 gene as a downstream target of hSNF5 that may provide a new therapeutic target for treatment of MRTs.
Materials and Methods
Cell culture and adenovirus infection. MCF7, A204.1, G401.6, TTC642, TM87-16 and TTC549 cells were cultured in RPMI 1640 containing 10% fetal bovine serum. The MCF7, A204 and G401 cell lines came from the American Type Tissue Collection and were used within 6 months of receipt or from frozen stocks within a similar timeframe. The remaining 3 cell lines came directly from their originator, Dr. Timothy Triche of the Children's Hospital of Los Angeles. Similar time limitations were also used to maintain the identities of these cell lines. The Ad/pAdEasyGFPINI-SV+ adenoviral vectors expressing hSNF5 and co-expressing the green fluorescent protein (GFP) (designated Ad-hSNF5) and the Ad/pAdEasyGFP expressing GFP (designated Ad-GFP) were previously published (9, 12, 13) . In order to achieve infection of over 90% cells, we infected at a plasmid DNA (pcDNA3, pcDNA3-fSNF5, pcDNA-wt-hNOXA) using Fugene 6 Reagent (Promega).
At 24h post transfection, each 10cm plate was split into 8x 10cm plates and placed on selective media containing 300μg/ml Neomycin (Gibco, Grand Island, NY). Two weeks after transfection, the plates were fixed with 95% ethanol and stained with Coomassie blue (50% Methanol, 10% Glacial Acetic Acid, 1g/L Coomasie Blue). Colonies with greater than 1000 cells were counted by visual inspection.
Protein extracts and Western blotting. Western blotting was carried out as described previously (13) . Western analyses of proteins were carried out by using anti-NOXA (OP180 ; Calbiochem), antihSNF5 (612110, BD-Transduction Laboratories) anti-actin (A2066; Sigma) and horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (GE Healthcare).
RNA extraction and Quantitative real-time reverse transcription-PCR analysis. RNA was extracted using the RNeasy mini kit (Qiagen), and 1 μg was used for cDNA synthesis primed with Random Primers (Invitrogen). cDNA was analyzed using TaqMan (Applied Biosystems) quantitative real-time reverse transcription-PCR (QT-PCR) analysis with beta-actin as the reference gene in each reaction. Reactions were performed on an ABI 7900 HT sequence detection system (Applied Biosystems) and relative quantification was determined using the 2 −ΔΔ Ct method (14, 15) .
The primers used The TaqMan gene expression assay primer/probe set used in this study is described in Table. 1.
Chromatin immunoprecipitation.
Chromatin immunoprecipitation (ChIP) was carried out as described by Donner et al (15) . Immunoprecipitation was performed with an antibody specific to Table 2 (15) .
Results
The effects of reexpression of hSNF5 on p53 target genes in MRT cell lines. To determine whether hSNF5 regulates additional p53 target genes, we analyzed the change of mRNA levels using Q-RT-PCR in 3 MRT cell lines, A204.1, TTC642 and TTC549, at 24 hrs. after infection with AdhSNF5 and Ad-GFP (negative control) adenoviruses (Kuwahara et al, 2010) . Reexpression of hSNF5 differentially modified expression of subsets of p53 target genes among the MRT cell lines (Figure 1 Figure 2b ). Furthermore, we tested whether NOXA protein levels increased after Ad-hSNF5 infection in comparison with Ad-GFP infection. We observed that the level of NOXA protein increased at 24 hours after AdhSNF5 infection in comparison with Ad-GFP infection in two MRT cell lines (TTC642 and TTC549), followed by a marked increase at 48 hours after infection ( Figure 3A ). Finally, we asked whether NOXA expression might contribute to the potent growth arrest induced by HSNF5. Using a colony forming assay, we found that both HSNF5 and NOXA expression in the TTC642 cell line gave similar levels of growth inhibition ( Figure 3B ).
Recruitment of hSNF5 on NOXA locus correlates with NOXA transcription in MRT cell lines.
We analyzed the chromatin status at NOXA promoter in both TTC642 and TTC549 cell, at 24 hours expression. This finding suggests that loss of hSNF5 expression might lead to an epigenetic modification at the NOXA promoter altering transcriptional activity.
Reexpression of hSNF5 induces p21 CIP1/WAF1 and NOXA transcription accompanied with SWI/SNF complex recruitment. In our previous report, we demonstrated that hSNF5 directly controlled p21 CIP1/WAF1 transcription activity. However, the mechanism of p21 CIP1/WAF1 and NOXA transcription activity induced by hSNF5 has not yet been clarified. To investigate the occupancy of reexpressed hSNF5 on the p21 CIP1/WAF1 locus, we first performed a ChIP assay for hSNF5, BAF155
and BRG-1 at 24 hrs. after infection of Ad-hSNF5 compared with Ad-GFP infection. We made sets of primers for the p21 CIP1/WAF1 promoter regions from -3000 to +4001 as previously described (15 and NOXA promoters (Figure 4c, Figure 5c ). These results imply that reexpression of hSNF5 presumably precedes the transcription elongation step (17).
p53 is not required for hSNF5-induced transcriptional activity on the NOXA and p21 CIP1/WAF1 promoters. We next determined whether hSNF5 recruitment to the NOXA promoter affected p53
binding. We performed a ChIP assay for p53 binding at these promoters in the TTC642 and TTC549 cell lines. We assessed p53 binding site on the NOXA promoter at -158bp, the consensus p53 binding site (18) , and did not observe binding after hSNF5 reexpression (Figure 4e ). In our previous study, we determined that up-regulation of p21 CIP1/WAF1 transcription by hSNF5 operated through a p53-dependent mechanism in A204.1 cells, but through a p53-independent mechanism in TTC642 cells (9) . To determine p53 dependency for NOXA transcription, we used 2 previously characterized p53 stable knock-down MRT cell lines from TTC642 cells and a negative control cell line (pLKO.1) (9). Infection of the pLKO.1 and p53KD cells with Ad-GFP did not alter levels of NOXA mRNA 24 hours after infection compared to the uninfected parental cell lines (Fig. 4f) .
However, we found an increase of NOXA mRNA after hSNF5 reexpression that was not significantly different among the TTC642, TTC642 pLKO.1 and TTC642 p53KD cells (Fig. 4f) . These observations suggest that hSNF5 binding could initiate transcription on the p21 CIP1/WAF1 and NOXA promoters in the TTC642 cell line without additional p53 recruitment.
Discussion
The objective of this study was to identify additional genes, besides p21 WAF/CIP1 , regulated by both hSNF5 and p53 in MRT cells and to determine the mechanism of hSNF5 regulation of their transcriptional activity. While HSNF5 could regulate expression of varying p53 target genes among the MRT cell lines, NOXA was the only common target gene in 5/6 cell lines. We then used ChIP analyses of the promoter regions of the p21 WAF/CIP1 and NOXA genes to understand how HSNF5 regulates their expression. Our results provide major insights into the control of hSNF5 target genes and how hSNF5 and the SWI/SNF complex functions in the regulation of their transcription.
Recently, Lee RS et al. demonstrated hSNF5 is the only gene recurrently mutated at a high frequency in MRTs (19). This finding implicates MRTs as true "epigenetically-driven" cancers and
indicates that downstream target genes of hSNF5 must drive tumorigenesis for this cancer. Because the patterns of epigenetic changes, especially those associated with chromatin landscape, can vary from cell to cell, it does not seem surprising that we observed a slightly different pattern of gene expression after restoration of HSNF5 expression in each MRT cell line. Our results also indicate that hSNF5 may regulate a subset of p53 target genes such as p21 CIP1/WAF1 and NOXA in MRT cell lines but generally through a p53-independent mechanism. Intriguingly, we observed an increase in NOXA mRNA and protein levels after reexpression of hSNF5 in most MRT cell lines. Our ChIP assays also showed that reexpression of hSNF5 increased NOXA transcriptional activity through the recruitment of BRG1 and RNAPII to the NOXA promoter. This is the first report that hSNF5 regulates NOXA transcriptional activity and establishes NOXA as a clinically relevant hSNF5 target gene. NOXA was initially identified as a phorbol ester-responsive gene (20) . The NOXA protein, containing a Bcl2 homology domain3 (BH- Our results also demonstrated the function of hSNF5 in the context of SWI/SNF complex. Some researchers have reported that reexpressed hSNF5 appeared at one or multiple sites within the promoters of several genes (13, (36) (37) (38) . In our previous report, we also demonstrated hSNF5 binds at a point close to the TSS on the p21 CIP1/WAF1 and p16 promoters by ChIP assay (9) . However, the pattern of hSNF5 occupancy of target gene promoters has remained unclear. Our results showed hSNF5 appeared on the promoter region with maximal enrichment site at the TSS. Kia and colleagues reported that on p16 promoter, reexpressed hSNF5 binds more at -0.3kb and +85 bp site than other upstream and downstream sites (13, 36, 37) . Our results with the p21 CIP1/WAF1 and NOXA promoters provide strong evidence that hSNF5 is generally associated with the transcriptional activity at TSS on its target genes. In contrast, BRG-1 and BAF155 occupancy increased equally from downstream to upstream on p21 CIP1/WAF1 and NOXA locus after reexpression of hSNF5. Therefore, our results indicate a discrepancy between hSNF5 occupancy and BRG-1 occupancy after hSNF5 reexpression. A more detailed analysis using ChIP-seq to identify the binding sites of the hSNF5 and the other SWI/SNF complex members will resolve this question. 
occupancy suggests that reexpressed hSNF5 potentially interacted with a H3K4 methyltransferase.
In contrast, our H3K36me3 ChIP data showed that H3K36me3 occupancy was detected in transcribed regions of the p21 CIP1/WAF1 and NOXA genes, peaking toward the 3' end (39) (40) (41) 44) . Our results concur with several earlier reports demonstrating (39) (40) (41) 44 ) that H3K36me3 occupancy tracks within the body of transcriptionally active genes and associates with transcriptional elongation activity. These histone modifications after hSNF5 reexpression indicate that hSNF5 can regulate the transcription initiation followed by elongation activity in MRT cells.
We also showed that RNAPII occupancy increased after hSNF5 reexpression on p21 CIP1/WAF1 and NOXA promoter. Guenther and colleagues found that most promoters (98%) occupied by RNAPII were also occupied by H3K4me3, whereas RNAPII occupied few genes (2%) that lack H3K4me3 (42, 45) . Other researchers have shown that components of H3K4 methyltransferase complexes interact with the Ser5-phosphorylated form of RNAPII, indicating that transcription initiation coincides with H3K4me3 deposition (45) . Similar studies showed that H3K4me3 modification occurs subsequent to RNAPII recruitment and Ser5 phosphorylation of RNAPII C-terminal domain (16, 40, 46) . Indeed, we also showed that the occupancy of RNAPII follows a similar pattern for H3K4me3 occupancy. The increase of H3K4me3 occupancy in the p21 CIP1/WAF1 and NOXA promoters may result from recruitment of H3K4 methyltransferase and RNAPII by hSNF5 reexpression.
However, H3K4me3 was still detected at the inactive NOXA promoter in the absence of hSNF5 with a low occupancy of RNAPII. Then, after reexpression of hSNF5, both RNAPII and H3K4me3 immediately increased on or near the TSS. Vastenhouw and colleagues indicated that many nonexpressed genes in ES cells also carry only H3K4me3 marks (44) . They also demonstrated most of these H3K4me3 domains are not associated with detectable levels of RNAPII, and H3K4me3 marks might be established in the absence of sequence-specific activators and without the stable association of RNAPII. These H3K4me3 domains might be paused genes for activation by creating a platform for the transcriptional machinery (12) . Our data suggest that the inactive NOXA gene in MRT cells might be paused by loss of hSNF5 and reexpression of hSNF5 can release the pausing followed by recruitment of RNAPII. On the other hand, because transcriptional activity appears at the p21 CIP1/WAF1 promoter, it has both H3K4me3 and RNAPII occupancy before reexpression of hSNF5. Taken together, hSNF5 can activate a transcription initiation step by recruitment of RNAPII accompanied with H3K4me3 nucleosome modification.
In conclusion, our results show that hSNF5 reexpression in MRT cells increases both 
